List of Similar Pattern of Amino Acids Hit pattern: 3D amino acid arrangements similar to known drug binding site Query pattern: Residues from known binding site for annotated drug that match the hit pattern (Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids) (Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc.
Hit PDBID
Hit Macromolecule
Res. Matches
Interface
HETATM
RMSD
Dali Z-score
Seq. Identity (%)
View
Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
GLY A 81GLY A 85GLY A 86TRP A 87ARG A 163LYS A 182
SAH A 500 (-3.4A)SAH A 500 ( 4.6A)SAH A 500 (-3.2A)SAH A 500 (-3.4A)NoneNone
1.30A
1eizA-2px5A:15.1
1eizA-2px5A:23.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
SAH A 500 (-3.4A)SAH A 500 ( 4.6A)SAH A 500 (-3.2A)SAH A 500 (-3.4A)None
0.67A
1ej0A-2px5A:15.0
1ej0A-2px5A:23.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
SAH A 500 (-3.4A)SAH A 500 ( 4.6A)SAH A 500 (-3.4A)SAH A 500 (-3.6A)None
0.66A
2nyuA-2px5A:14.4
2nyuA-2px5A:22.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104GLU A 111ASP A 131VAL A 132ASP A 146ILE A 147
SAH A 500 (-3.3A)SAH A 500 (-3.4A)SAH A 500 ( 3.7A)SAH A 500 (-3.2A)SAH A 500 (-3.4A)SAH A 500 ( 4.6A)SAH A 500 ( 3.2A)SAH A 500 (-3.5A)SAH A 500 (-3.6A)SAH A 500 (-3.6A)SAH A 500 ( 4.3A)
0.22A
2pxcA-2px5A:44.7
2pxcA-2px5A:100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2PXC_A_SAMA500_0 (GENOME POLYPROTEIN[CONTAINS: CAPSIDPROTEIN C (COREPROTEIN) ENVELOPE PROTEIN M(MATRIX PROTEIN) MAJOR ENVELOPEPROTEIN E NON-STRUCTURALPROTEIN 1 (NS1) NON-STRUCTURALPROTEIN 2A (NS2A) FLAVIVIRIN PROTEASENS2B REGULATORYSUBUNIT FLAVIVIRIN PROTEASENS3 CATALYTICSUBUNIT NON-STRUCTURALPROTEIN 4A (NS4A) NON-STRUCTURALPROTEIN 4B (NS4B) RNA-DIRECTED RNAPOLYMERASE (EC2.7.7.48) (NS5)])
SER A 56GLY A 58GLY A 81GLY A 83TRP A 87THR A 104VAL A 132ASP A 146ILE A 147
SAH A 500 (-2.5A)SAH A 500 (-3.3A)SAH A 500 (-3.4A)SAH A 500 ( 3.7A)SAH A 500 (-3.4A)SAH A 500 ( 4.6A)SAH A 500 (-3.6A)SAH A 500 (-3.6A)SAH A 500 ( 4.3A)
0.32A
2wa2B-2px5A:40.7
2wa2B-2px5A:48.92
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
SAH A 500 (-2.5A)SAH A 500 (-3.3A)SAH A 500 ( 3.7A)SAH A 500 ( 4.6A)SAH A 500 ( 3.2A)
0.97A
2wa2B-2px5A:40.7
2wa2B-2px5A:48.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104VAL A 132PHE A 133ASP A 146ILE A 147
SAH A 500 (-3.3A)SAH A 500 (-3.4A)SAH A 500 ( 3.7A)SAH A 500 (-3.2A)SAH A 500 (-3.4A)SAH A 500 ( 4.6A)SAH A 500 (-3.6A)SAH A 500 (-4.2A)SAH A 500 (-3.6A)SAH A 500 ( 4.3A)
0.38A
3eluA-2px5A:40.1
3eluA-2px5A:54.29
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104VAL A 132PHE A 133ASP A 146ILE A 147
SAH A 500 (-3.3A)SAH A 500 (-3.4A)SAH A 500 ( 3.7A)SAH A 500 (-3.2A)SAH A 500 (-3.4A)SAH A 500 ( 4.6A)SAH A 500 (-3.6A)SAH A 500 (-4.2A)SAH A 500 (-3.6A)SAH A 500 ( 4.3A)
0.36A
3elwA-2px5A:41.7
3elwA-2px5A:54.29
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104VAL A 132ASP A 146ILE A 147
SAH A 500 (-3.3A)SAH A 500 (-3.4A)SAH A 500 ( 3.7A)SAH A 500 (-3.2A)SAH A 500 (-3.4A)SAH A 500 ( 4.6A)SAH A 500 (-3.6A)SAH A 500 (-3.6A)SAH A 500 ( 4.3A)
0.25A
3embA-2px5A:40.6
3embA-2px5A:54.29
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
GLY A 58GLY A 81GLY A 83TRP A 87THR A 104GLU A 111VAL A 132ASP A 146ILE A 147
SAH A 500 (-3.3A)SAH A 500 (-3.4A)SAH A 500 ( 3.7A)SAH A 500 (-3.4A)SAH A 500 ( 4.6A)SAH A 500 ( 3.2A)SAH A 500 (-3.6A)SAH A 500 (-3.6A)SAH A 500 ( 4.3A)
0.44A
3embA-2px5A:40.6
3embA-2px5A:54.29
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
SER A 56GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104ASP A 131VAL A 132ASP A 146ILE A 147
SAH A 500 (-2.5A)SAH A 500 (-3.3A)SAH A 500 (-3.4A)SAH A 500 ( 3.7A)SAH A 500 (-3.2A)SAH A 500 (-3.4A)SAH A 500 ( 4.6A)SAH A 500 (-3.5A)SAH A 500 (-3.6A)SAH A 500 (-3.6A)SAH A 500 ( 4.3A)
0.28A
3gczA-2px5A:41.2
3gczA-2px5A:54.68
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104HIS A 110ASP A 131VAL A 132ASP A 146ILE A 147
SAH A 500 (-3.3A)SAH A 500 (-3.4A)SAH A 500 ( 3.7A)SAH A 500 (-3.2A)SAH A 500 (-3.4A)SAH A 500 ( 4.6A)SAH A 500 (-3.9A)SAH A 500 (-3.5A)SAH A 500 (-3.6A)SAH A 500 (-3.6A)SAH A 500 ( 4.3A)
0.50A
3p97A-2px5A:41.3
3p97A-2px5A:60.22
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
GLY A 81GLY A 83GLY A 86TRP A 87THR A 104LYS A 105HIS A 110ASP A 131VAL A 132ASP A 146ILE A 147
SAH A 500 (-3.4A)SAH A 500 ( 3.7A)SAH A 500 (-3.2A)SAH A 500 (-3.4A)SAH A 500 ( 4.6A)NoneSAH A 500 (-3.9A)SAH A 500 (-3.5A)SAH A 500 (-3.6A)SAH A 500 (-3.6A)SAH A 500 ( 4.3A)
0.75A
3p97A-2px5A:41.3
3p97A-2px5A:60.22
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104ASP A 131VAL A 132ASP A 146ILE A 147
SAH A 500 (-3.3A)SAH A 500 (-3.4A)SAH A 500 ( 3.7A)SAH A 500 (-3.2A)SAH A 500 (-3.4A)SAH A 500 ( 4.6A)SAH A 500 (-3.5A)SAH A 500 (-3.6A)SAH A 500 (-3.6A)SAH A 500 ( 4.3A)
0.39A
3p97C-2px5A:41.2
3p97C-2px5A:60.22
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104LYS A 105VAL A 132ASP A 146ILE A 147
SAH A 500 (-3.3A)SAH A 500 (-3.4A)SAH A 500 ( 3.7A)SAH A 500 (-3.2A)SAH A 500 (-3.4A)SAH A 500 ( 4.6A)NoneSAH A 500 (-3.6A)SAH A 500 (-3.6A)SAH A 500 ( 4.3A)
0.67A
3p97C-2px5A:41.2
3p97C-2px5A:60.22
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
GLY A 58GLY A 83GLY A 86TRP A 87THR A 104GLU A 111
SAH A 500 (-3.3A)SAH A 500 ( 3.7A)SAH A 500 (-3.2A)SAH A 500 (-3.4A)SAH A 500 ( 4.6A)SAH A 500 ( 3.2A)
0.94A
3p97C-2px5A:41.2
3p97C-2px5A:60.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104ASP A 131VAL A 132ASP A 146ILE A 147
SAH A 500 (-3.3A)SAH A 500 (-3.4A)SAH A 500 ( 3.7A)SAH A 500 (-3.2A)SAH A 500 (-3.4A)SAH A 500 ( 4.6A)SAH A 500 (-3.5A)SAH A 500 (-3.6A)SAH A 500 (-3.6A)SAH A 500 ( 4.3A)
0.29A
4ctjA-2px5A:41.3
4ctjA-2px5A:60.44
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
GLY A 81GLY A 83GLY A 86TRP A 87THR A 104LYS A 105ASP A 131VAL A 132ASP A 146ILE A 147
SAH A 500 (-3.4A)SAH A 500 ( 3.7A)SAH A 500 (-3.2A)SAH A 500 (-3.4A)SAH A 500 ( 4.6A)NoneSAH A 500 (-3.5A)SAH A 500 (-3.6A)SAH A 500 (-3.6A)SAH A 500 ( 4.3A)
0.65A
4ctjA-2px5A:41.3
4ctjA-2px5A:60.44
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104LYS A 105HIS A 110VAL A 132ASP A 146ILE A 147
SAH A 500 (-3.3A)SAH A 500 (-3.4A)SAH A 500 ( 3.7A)SAH A 500 (-3.2A)SAH A 500 (-3.4A)SAH A 500 ( 4.6A)NoneSAH A 500 (-3.9A)SAH A 500 (-3.6A)SAH A 500 (-3.6A)SAH A 500 ( 4.3A)
0.61A
4ctjC-2px5A:41.2
4ctjC-2px5A:60.44
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104GLU A 111ASP A 131VAL A 132ASP A 146ILE A 147
SAH A 500 (-3.3A)SAH A 500 (-3.4A)SAH A 500 ( 3.7A)SAH A 500 (-3.2A)SAH A 500 (-3.4A)SAH A 500 ( 4.6A)SAH A 500 ( 3.2A)SAH A 500 (-3.5A)SAH A 500 (-3.6A)SAH A 500 (-3.6A)SAH A 500 ( 4.3A)
0.32A
4ctkA-2px5A:41.3
4ctkA-2px5A:60.44
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
GLY A 81GLY A 83GLY A 86TRP A 87THR A 104LYS A 105ASP A 131VAL A 132ASP A 146ILE A 147
SAH A 500 (-3.4A)SAH A 500 ( 3.7A)SAH A 500 (-3.2A)SAH A 500 (-3.4A)SAH A 500 ( 4.6A)NoneSAH A 500 (-3.5A)SAH A 500 (-3.6A)SAH A 500 (-3.6A)SAH A 500 ( 4.3A)
0.65A
4ctkA-2px5A:41.3
4ctkA-2px5A:60.44
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104LYS A 105VAL A 132ASP A 146ILE A 147
SAH A 500 (-3.3A)SAH A 500 (-3.4A)SAH A 500 ( 3.7A)SAH A 500 (-3.2A)SAH A 500 (-3.4A)SAH A 500 ( 4.6A)NoneSAH A 500 (-3.6A)SAH A 500 (-3.6A)SAH A 500 ( 4.3A)
0.82A
4ctkC-2px5A:41.2
4ctkC-2px5A:60.44
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
SER A 56GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104VAL A 132ASP A 146ILE A 147
SAH A 500 (-2.5A)SAH A 500 (-3.3A)SAH A 500 (-3.4A)SAH A 500 ( 3.7A)SAH A 500 (-3.2A)SAH A 500 (-3.4A)SAH A 500 ( 4.6A)SAH A 500 (-3.6A)SAH A 500 (-3.6A)SAH A 500 ( 4.3A)
0.31A
4ctkC-2px5A:41.2
4ctkC-2px5A:60.44
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
SER A 56GLY A 58GLY A 83GLY A 86THR A 104GLU A 111
SAH A 500 (-2.5A)SAH A 500 (-3.3A)SAH A 500 ( 3.7A)SAH A 500 (-3.2A)SAH A 500 ( 4.6A)SAH A 500 ( 3.2A)
0.96A
4ctkC-2px5A:41.2
4ctkC-2px5A:60.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
SAH A 500 (-2.5A)SAH A 500 (-3.5A)SAH A 500 (-3.6A)
0.66A
4uckA-2px5A:8.6
4uckA-2px5A:20.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104GLU A 111ASP A 131VAL A 132ASP A 146ILE A 147
SAH A 500 (-3.3A)SAH A 500 (-3.4A)SAH A 500 ( 3.7A)SAH A 500 (-3.2A)SAH A 500 (-3.4A)SAH A 500 ( 4.6A)SAH A 500 ( 3.2A)SAH A 500 (-3.5A)SAH A 500 (-3.6A)SAH A 500 (-3.6A)SAH A 500 ( 4.3A)
0.32A
5e9qA-2px5A:41.0
5e9qA-2px5A:60.45
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104GLU A 111ASP A 131VAL A 132ASP A 146ILE A 147
SAH A 500 (-3.3A)SAH A 500 (-3.4A)SAH A 500 ( 3.7A)SAH A 500 (-3.2A)SAH A 500 (-3.4A)SAH A 500 ( 4.6A)SAH A 500 ( 3.2A)SAH A 500 (-3.5A)SAH A 500 (-3.6A)SAH A 500 (-3.6A)SAH A 500 ( 4.3A)
0.44A
5e9qC-2px5A:41.1
5e9qC-2px5A:60.45
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
SER A 56GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104GLU A 111VAL A 132ASP A 146ILE A 147
SAH A 500 (-2.5A)SAH A 500 (-3.3A)SAH A 500 (-3.4A)SAH A 500 ( 3.7A)SAH A 500 (-3.2A)SAH A 500 (-3.4A)SAH A 500 ( 4.6A)SAH A 500 ( 3.2A)SAH A 500 (-3.6A)SAH A 500 (-3.6A)SAH A 500 ( 4.3A)
0.33A
5ec8A-2px5A:41.1
5ec8A-2px5A:60.44
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104ASP A 131VAL A 132ASP A 146ILE A 147
SAH A 500 (-3.3A)SAH A 500 (-3.4A)SAH A 500 ( 3.7A)SAH A 500 (-3.2A)SAH A 500 (-3.4A)SAH A 500 ( 4.6A)SAH A 500 (-3.5A)SAH A 500 (-3.6A)SAH A 500 (-3.6A)SAH A 500 ( 4.3A)
0.36A
5ec8C-2px5A:40.9
5ec8C-2px5A:60.44
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104GLU A 111ASP A 131VAL A 132ASP A 146ILE A 147
SAH A 500 (-3.3A)SAH A 500 (-3.4A)SAH A 500 ( 3.7A)SAH A 500 (-3.2A)SAH A 500 (-3.4A)SAH A 500 ( 4.6A)SAH A 500 ( 3.2A)SAH A 500 (-3.5A)SAH A 500 (-3.6A)SAH A 500 (-3.6A)SAH A 500 ( 4.3A)
0.39A
5ehgA-2px5A:41.1
5ehgA-2px5A:60.44
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
GLY A 81GLY A 83GLY A 86TRP A 87THR A 104LYS A 105ASP A 131VAL A 132ASP A 146ILE A 147
SAH A 500 (-3.4A)SAH A 500 ( 3.7A)SAH A 500 (-3.2A)SAH A 500 (-3.4A)SAH A 500 ( 4.6A)NoneSAH A 500 (-3.5A)SAH A 500 (-3.6A)SAH A 500 (-3.6A)SAH A 500 ( 4.3A)
0.68A
5ehgA-2px5A:41.1
5ehgA-2px5A:60.44
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104HIS A 110GLU A 111VAL A 132ASP A 146ILE A 147
SAH A 500 (-3.3A)SAH A 500 (-3.4A)SAH A 500 ( 3.7A)SAH A 500 (-3.2A)SAH A 500 (-3.4A)SAH A 500 ( 4.6A)SAH A 500 (-3.9A)SAH A 500 ( 3.2A)SAH A 500 (-3.6A)SAH A 500 (-3.6A)SAH A 500 ( 4.3A)
0.43A
5ehgC-2px5A:41.1
5ehgC-2px5A:60.44
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104ASP A 131VAL A 132ASP A 146ILE A 147
SAH A 500 (-3.3A)SAH A 500 (-3.4A)SAH A 500 ( 3.7A)SAH A 500 (-3.2A)SAH A 500 (-3.4A)SAH A 500 ( 4.6A)SAH A 500 (-3.5A)SAH A 500 (-3.6A)SAH A 500 (-3.6A)SAH A 500 ( 4.3A)
0.29A
5ehiA-2px5A:41.3
5ehiA-2px5A:60.44
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104LYS A 105ASP A 131VAL A 132ASP A 146ILE A 147
SAH A 500 (-3.3A)SAH A 500 (-3.4A)SAH A 500 ( 3.7A)SAH A 500 (-3.2A)SAH A 500 (-3.4A)SAH A 500 ( 4.6A)NoneSAH A 500 (-3.5A)SAH A 500 (-3.6A)SAH A 500 (-3.6A)SAH A 500 ( 4.3A)
0.46A
5ehiC-2px5A:41.4
5ehiC-2px5A:60.44
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104GLU A 111ASP A 131VAL A 132ASP A 146ILE A 147
SAH A 500 (-3.3A)SAH A 500 (-3.4A)SAH A 500 ( 3.7A)SAH A 500 (-3.2A)SAH A 500 (-3.4A)SAH A 500 ( 4.6A)SAH A 500 ( 3.2A)SAH A 500 (-3.5A)SAH A 500 (-3.6A)SAH A 500 (-3.6A)SAH A 500 ( 4.3A)
0.30A
5eifA-2px5A:41.3
5eifA-2px5A:60.44
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
GLY A 81GLY A 83GLY A 86TRP A 87THR A 104LYS A 105ASP A 131VAL A 132ASP A 146ILE A 147
SAH A 500 (-3.4A)SAH A 500 ( 3.7A)SAH A 500 (-3.2A)SAH A 500 (-3.4A)SAH A 500 ( 4.6A)NoneSAH A 500 (-3.5A)SAH A 500 (-3.6A)SAH A 500 (-3.6A)SAH A 500 ( 4.3A)
0.66A
5eifA-2px5A:41.3
5eifA-2px5A:60.44
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104LYS A 105GLU A 111ASP A 131VAL A 132ASP A 146ILE A 147
SAH A 500 (-3.3A)SAH A 500 (-3.4A)SAH A 500 ( 3.7A)SAH A 500 (-3.2A)SAH A 500 (-3.4A)SAH A 500 ( 4.6A)NoneSAH A 500 ( 3.2A)SAH A 500 (-3.5A)SAH A 500 (-3.6A)SAH A 500 (-3.6A)SAH A 500 ( 4.3A)
0.47A
5eifC-2px5A:41.2
5eifC-2px5A:60.44
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104ASP A 131VAL A 132ASP A 146ILE A 147
SAH A 500 (-3.3A)SAH A 500 (-3.4A)SAH A 500 ( 3.7A)SAH A 500 (-3.2A)SAH A 500 (-3.4A)SAH A 500 ( 4.6A)SAH A 500 (-3.5A)SAH A 500 (-3.6A)SAH A 500 (-3.6A)SAH A 500 ( 4.3A)
0.33A
5eiwA-2px5A:41.1
5eiwA-2px5A:60.44
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104GLU A 111ASP A 131VAL A 132ASP A 146ILE A 147
SAH A 500 (-3.3A)SAH A 500 (-3.4A)SAH A 500 ( 3.7A)SAH A 500 (-3.2A)SAH A 500 (-3.4A)SAH A 500 ( 4.6A)SAH A 500 ( 3.2A)SAH A 500 (-3.5A)SAH A 500 (-3.6A)SAH A 500 (-3.6A)SAH A 500 ( 4.3A)
0.36A
5eiwC-2px5A:41.3
5eiwC-2px5A:60.44
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104LYS A 105VAL A 132ASP A 146ILE A 147
SAH A 500 (-3.3A)SAH A 500 (-3.4A)SAH A 500 ( 3.7A)SAH A 500 (-3.2A)SAH A 500 (-3.4A)SAH A 500 ( 4.6A)NoneSAH A 500 (-3.6A)SAH A 500 (-3.6A)SAH A 500 ( 4.3A)
0.70A
5eiwC-2px5A:41.3
5eiwC-2px5A:60.44
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
SER A 56GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104ASP A 131VAL A 132ASP A 146ILE A 147
SAH A 500 (-2.5A)SAH A 500 (-3.3A)SAH A 500 (-3.4A)SAH A 500 ( 3.7A)SAH A 500 (-3.2A)SAH A 500 (-3.4A)SAH A 500 ( 4.6A)SAH A 500 (-3.5A)SAH A 500 (-3.6A)SAH A 500 (-3.6A)SAH A 500 ( 4.3A)
0.29A
5ekxA-2px5A:41.4
5ekxA-2px5A:60.44
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104HIS A 110VAL A 132ASP A 146ILE A 147
SAH A 500 (-3.3A)SAH A 500 (-3.4A)SAH A 500 ( 3.7A)SAH A 500 (-3.2A)SAH A 500 (-3.4A)SAH A 500 ( 4.6A)SAH A 500 (-3.9A)SAH A 500 (-3.6A)SAH A 500 (-3.6A)SAH A 500 ( 4.3A)
0.44A
5ekxB-2px5A:41.4
5ekxB-2px5A:60.44
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104LYS A 105HIS A 110ASP A 131VAL A 132ASP A 146ILE A 147
SAH A 500 (-3.3A)SAH A 500 (-3.4A)SAH A 500 ( 3.7A)SAH A 500 (-3.2A)SAH A 500 (-3.4A)SAH A 500 ( 4.6A)NoneSAH A 500 (-3.9A)SAH A 500 (-3.5A)SAH A 500 (-3.6A)SAH A 500 (-3.6A)SAH A 500 ( 4.3A)
0.56A
5ikmA-2px5A:41.8
5ikmA-2px5A:61.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104HIS A 110GLU A 111ASP A 131VAL A 132ILE A 147
SAH A 500 (-3.3A)SAH A 500 (-3.4A)SAH A 500 ( 3.7A)SAH A 500 (-3.2A)SAH A 500 (-3.4A)SAH A 500 ( 4.6A)SAH A 500 (-3.9A)SAH A 500 ( 3.2A)SAH A 500 (-3.5A)SAH A 500 (-3.6A)SAH A 500 ( 4.3A)
0.44A
5kqrA-2px5A:43.3
5kqrA-2px5A:68.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104HIS A 110ASP A 131VAL A 132ASP A 146ILE A 147
SAH A 500 (-3.3A)SAH A 500 (-3.4A)SAH A 500 ( 3.7A)SAH A 500 (-3.2A)SAH A 500 (-3.4A)SAH A 500 ( 4.6A)SAH A 500 (-3.9A)SAH A 500 (-3.5A)SAH A 500 (-3.6A)SAH A 500 (-3.6A)SAH A 500 ( 4.3A)
0.40A
5kqsA-2px5A:42.8
5kqsA-2px5A:68.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104HIS A 110GLU A 111ASP A 131VAL A 132ILE A 147
SAH A 500 (-3.3A)SAH A 500 (-3.4A)SAH A 500 ( 3.7A)SAH A 500 (-3.2A)SAH A 500 (-3.4A)SAH A 500 ( 4.6A)SAH A 500 (-3.9A)SAH A 500 ( 3.2A)SAH A 500 (-3.5A)SAH A 500 (-3.6A)SAH A 500 ( 4.3A)
0.54A
5m5bA-2px5A:42.9
5m5bA-2px5A:67.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104HIS A 110ASP A 131VAL A 132ASP A 146ILE A 147
SAH A 500 (-3.3A)SAH A 500 (-3.4A)SAH A 500 ( 3.7A)SAH A 500 (-3.2A)SAH A 500 (-3.4A)SAH A 500 ( 4.6A)SAH A 500 (-3.9A)SAH A 500 (-3.5A)SAH A 500 (-3.6A)SAH A 500 (-3.6A)SAH A 500 ( 4.3A)
0.42A
5njvA-2px5A:42.0
5njvA-2px5A:67.41
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104HIS A 110ASP A 131VAL A 132ASP A 146ILE A 147
SAH A 500 (-3.3A)SAH A 500 (-3.4A)SAH A 500 ( 3.7A)SAH A 500 (-3.2A)SAH A 500 (-3.4A)SAH A 500 ( 4.6A)SAH A 500 (-3.9A)SAH A 500 (-3.5A)SAH A 500 (-3.6A)SAH A 500 (-3.6A)SAH A 500 ( 4.3A)
0.37A
5njvB-2px5A:42.4
5njvB-2px5A:67.41
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104HIS A 110GLU A 111VAL A 132ASP A 146ILE A 147
SAH A 500 (-3.3A)SAH A 500 (-3.4A)SAH A 500 ( 3.7A)SAH A 500 (-3.2A)SAH A 500 (-3.4A)SAH A 500 ( 4.6A)SAH A 500 (-3.9A)SAH A 500 ( 3.2A)SAH A 500 (-3.6A)SAH A 500 (-3.6A)SAH A 500 ( 4.3A)
0.55A
5njvC-2px5A:41.3
5njvC-2px5A:67.41
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104LYS A 105HIS A 110VAL A 132ASP A 146ILE A 147
SAH A 500 (-3.3A)SAH A 500 (-3.4A)SAH A 500 ( 3.7A)SAH A 500 (-3.2A)SAH A 500 (-3.4A)SAH A 500 ( 4.6A)NoneSAH A 500 (-3.9A)SAH A 500 (-3.6A)SAH A 500 (-3.6A)SAH A 500 ( 4.3A)
0.72A
5njvC-2px5A:41.3
5njvC-2px5A:67.41
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
GLY A 58GLY A 81GLY A 83TRP A 87THR A 104LYS A 105HIS A 110ASP A 131VAL A 132ASP A 146ILE A 147
SAH A 500 (-3.3A)SAH A 500 (-3.4A)SAH A 500 ( 3.7A)SAH A 500 (-3.4A)SAH A 500 ( 4.6A)NoneSAH A 500 (-3.9A)SAH A 500 (-3.5A)SAH A 500 (-3.6A)SAH A 500 (-3.6A)SAH A 500 ( 4.3A)
0.51A
5njvD-2px5A:41.2
5njvD-2px5A:67.41
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87LYS A 105HIS A 110GLU A 111VAL A 132PHE A 133ILE A 147LYS A 182
SAH A 500 (-3.3A)SAH A 500 (-3.4A)SAH A 500 ( 3.7A)SAH A 500 (-3.2A)SAH A 500 (-3.4A)NoneSAH A 500 (-3.9A)SAH A 500 ( 3.2A)SAH A 500 (-3.6A)SAH A 500 (-4.2A)SAH A 500 ( 4.3A)None
0.45A
5vimA-2px5A:42.1
5vimA-2px5A:69.26
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87LYS A 105HIS A 110GLU A 111VAL A 132PHE A 133ILE A 147LYS A 182
SAH A 500 (-3.3A)SAH A 500 (-3.4A)SAH A 500 ( 3.7A)SAH A 500 (-3.2A)SAH A 500 (-3.4A)NoneSAH A 500 (-3.9A)SAH A 500 ( 3.2A)SAH A 500 (-3.6A)SAH A 500 (-4.2A)SAH A 500 ( 4.3A)None
0.56A
5vimB-2px5A:42.1
5vimB-2px5A:69.26
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
GLY A 58GLY A 81GLY A 86TRP A 87THR A 104GLU A 111ASP A 131VAL A 132ASP A 146
SAH A 500 (-3.3A)SAH A 500 (-3.4A)SAH A 500 (-3.2A)SAH A 500 (-3.4A)SAH A 500 ( 4.6A)SAH A 500 ( 3.2A)SAH A 500 (-3.5A)SAH A 500 (-3.6A)SAH A 500 (-3.6A)
0.61A
5wz1A-2px5A:41.7
5wz1A-2px5A:66.91
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
GLY A 58GLY A 81GLY A 86TRP A 87THR A 104HIS A 110ASP A 131VAL A 132ASP A 146ILE A 147
SAH A 500 (-3.3A)SAH A 500 (-3.4A)SAH A 500 (-3.2A)SAH A 500 (-3.4A)SAH A 500 ( 4.6A)SAH A 500 (-3.9A)SAH A 500 (-3.5A)SAH A 500 (-3.6A)SAH A 500 (-3.6A)SAH A 500 ( 4.3A)
0.49A
5wz1A-2px5A:41.7
5wz1A-2px5A:66.91
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
GLY A 58GLY A 81GLY A 86TRP A 87THR A 104LYS A 105HIS A 110VAL A 132ASP A 146ILE A 147
SAH A 500 (-3.3A)SAH A 500 (-3.4A)SAH A 500 (-3.2A)SAH A 500 (-3.4A)SAH A 500 ( 4.6A)NoneSAH A 500 (-3.9A)SAH A 500 (-3.6A)SAH A 500 (-3.6A)SAH A 500 ( 4.3A)
0.79A
5wz1A-2px5A:41.7
5wz1A-2px5A:66.91
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104LYS A 105HIS A 110ASP A 131VAL A 132ILE A 147
SAH A 500 (-3.3A)SAH A 500 (-3.4A)SAH A 500 ( 3.7A)SAH A 500 (-3.2A)SAH A 500 (-3.4A)SAH A 500 ( 4.6A)NoneSAH A 500 (-3.9A)SAH A 500 (-3.5A)SAH A 500 (-3.6A)SAH A 500 ( 4.3A)
0.76A
5wz1B-2px5A:41.7
5wz1B-2px5A:66.91
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
GLY A 58GLY A 81GLY A 86TRP A 87THR A 104HIS A 110ASP A 131VAL A 132ASP A 146ILE A 147
SAH A 500 (-3.3A)SAH A 500 (-3.4A)SAH A 500 (-3.2A)SAH A 500 (-3.4A)SAH A 500 ( 4.6A)SAH A 500 (-3.9A)SAH A 500 (-3.5A)SAH A 500 (-3.6A)SAH A 500 (-3.6A)SAH A 500 ( 4.3A)
0.54A
5wz1C-2px5A:41.5
5wz1C-2px5A:66.91
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
GLY A 81GLY A 86TRP A 87THR A 104LYS A 105HIS A 110ASP A 131VAL A 132ASP A 146ILE A 147
SAH A 500 (-3.4A)SAH A 500 (-3.2A)SAH A 500 (-3.4A)SAH A 500 ( 4.6A)NoneSAH A 500 (-3.9A)SAH A 500 (-3.5A)SAH A 500 (-3.6A)SAH A 500 (-3.6A)SAH A 500 ( 4.3A)
0.76A
5wz1C-2px5A:41.5
5wz1C-2px5A:66.91
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
GLY A 58GLY A 81GLY A 86TRP A 87THR A 104LYS A 105HIS A 110ASP A 131VAL A 132ASP A 146ILE A 147
SAH A 500 (-3.3A)SAH A 500 (-3.4A)SAH A 500 (-3.2A)SAH A 500 (-3.4A)SAH A 500 ( 4.6A)NoneSAH A 500 (-3.9A)SAH A 500 (-3.5A)SAH A 500 (-3.6A)SAH A 500 (-3.6A)SAH A 500 ( 4.3A)
0.76A
5wz1D-2px5A:41.7
5wz1D-2px5A:66.91
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
GLY A 58GLY A 81GLY A 86TRP A 87THR A 104HIS A 110ASP A 131VAL A 132ASP A 146ILE A 147
SAH A 500 (-3.3A)SAH A 500 (-3.4A)SAH A 500 (-3.2A)SAH A 500 (-3.4A)SAH A 500 ( 4.6A)SAH A 500 (-3.9A)SAH A 500 (-3.5A)SAH A 500 (-3.6A)SAH A 500 (-3.6A)SAH A 500 ( 4.3A)
0.53A
5wz1E-2px5A:41.5
5wz1E-2px5A:66.91
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
GLY A 81GLY A 86TRP A 87THR A 104LYS A 105HIS A 110ASP A 131VAL A 132ASP A 146ILE A 147
SAH A 500 (-3.4A)SAH A 500 (-3.2A)SAH A 500 (-3.4A)SAH A 500 ( 4.6A)NoneSAH A 500 (-3.9A)SAH A 500 (-3.5A)SAH A 500 (-3.6A)SAH A 500 (-3.6A)SAH A 500 ( 4.3A)
0.76A
5wz1E-2px5A:41.5
5wz1E-2px5A:66.91
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
GLY A 58GLY A 81GLY A 86TRP A 87THR A 104LYS A 105HIS A 110ASP A 131VAL A 132ASP A 146ILE A 147
SAH A 500 (-3.3A)SAH A 500 (-3.4A)SAH A 500 (-3.2A)SAH A 500 (-3.4A)SAH A 500 ( 4.6A)NoneSAH A 500 (-3.9A)SAH A 500 (-3.5A)SAH A 500 (-3.6A)SAH A 500 (-3.6A)SAH A 500 ( 4.3A)
0.75A
5wz1F-2px5A:41.7
5wz1F-2px5A:66.91
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
GLY A 58GLY A 81GLY A 86TRP A 87THR A 104HIS A 110ASP A 131VAL A 132ASP A 146ILE A 147
SAH A 500 (-3.3A)SAH A 500 (-3.4A)SAH A 500 (-3.2A)SAH A 500 (-3.4A)SAH A 500 ( 4.6A)SAH A 500 (-3.9A)SAH A 500 (-3.5A)SAH A 500 (-3.6A)SAH A 500 (-3.6A)SAH A 500 ( 4.3A)
0.51A
5wz1G-2px5A:41.5
5wz1G-2px5A:66.91
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
GLY A 81GLY A 86TRP A 87THR A 104LYS A 105HIS A 110ASP A 131VAL A 132ASP A 146ILE A 147
SAH A 500 (-3.4A)SAH A 500 (-3.2A)SAH A 500 (-3.4A)SAH A 500 ( 4.6A)NoneSAH A 500 (-3.9A)SAH A 500 (-3.5A)SAH A 500 (-3.6A)SAH A 500 (-3.6A)SAH A 500 ( 4.3A)
0.74A
5wz1G-2px5A:41.5
5wz1G-2px5A:66.91
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
GLY A 58GLY A 81GLY A 86TRP A 87THR A 104HIS A 110ASP A 131VAL A 132ASP A 146ILE A 147
SAH A 500 (-3.3A)SAH A 500 (-3.4A)SAH A 500 (-3.2A)SAH A 500 (-3.4A)SAH A 500 ( 4.6A)SAH A 500 (-3.9A)SAH A 500 (-3.5A)SAH A 500 (-3.6A)SAH A 500 (-3.6A)SAH A 500 ( 4.3A)
0.53A
5wz1H-2px5A:41.5
5wz1H-2px5A:66.91
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
GLY A 81GLY A 86TRP A 87THR A 104LYS A 105HIS A 110ASP A 131VAL A 132ASP A 146ILE A 147
SAH A 500 (-3.4A)SAH A 500 (-3.2A)SAH A 500 (-3.4A)SAH A 500 ( 4.6A)NoneSAH A 500 (-3.9A)SAH A 500 (-3.5A)SAH A 500 (-3.6A)SAH A 500 (-3.6A)SAH A 500 ( 4.3A)
0.76A
5wz1H-2px5A:41.5
5wz1H-2px5A:66.91
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104HIS A 110ASP A 131VAL A 132ASP A 146ILE A 147
SAH A 500 (-3.3A)SAH A 500 (-3.4A)SAH A 500 ( 3.7A)SAH A 500 (-3.2A)SAH A 500 (-3.4A)SAH A 500 ( 4.6A)SAH A 500 (-3.9A)SAH A 500 (-3.5A)SAH A 500 (-3.6A)SAH A 500 (-3.6A)SAH A 500 ( 4.3A)
0.40A
5wz2A-2px5A:41.8
5wz2A-2px5A:66.91
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104HIS A 110ASP A 131VAL A 132ASP A 146ILE A 147
SAH A 500 (-3.3A)SAH A 500 (-3.4A)SAH A 500 ( 3.7A)SAH A 500 (-3.2A)SAH A 500 (-3.4A)SAH A 500 ( 4.6A)SAH A 500 (-3.9A)SAH A 500 (-3.5A)SAH A 500 (-3.6A)SAH A 500 (-3.6A)SAH A 500 ( 4.3A)
0.40A
5wz2B-2px5A:42.0
5wz2B-2px5A:66.91
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104HIS A 110VAL A 132ASP A 146ILE A 147
SAH A 500 (-3.3A)SAH A 500 (-3.4A)SAH A 500 ( 3.7A)SAH A 500 (-3.2A)SAH A 500 (-3.4A)SAH A 500 ( 4.6A)SAH A 500 (-3.9A)SAH A 500 (-3.6A)SAH A 500 (-3.6A)SAH A 500 ( 4.3A)
0.43A
5wz2C-2px5A:41.8
5wz2C-2px5A:66.91
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
GLY A 81GLY A 83TRP A 87THR A 104GLU A 111VAL A 132ASP A 146ILE A 147
SAH A 500 (-3.4A)SAH A 500 ( 3.7A)SAH A 500 (-3.4A)SAH A 500 ( 4.6A)SAH A 500 ( 3.2A)SAH A 500 (-3.6A)SAH A 500 (-3.6A)SAH A 500 ( 4.3A)
0.69A
5wz2C-2px5A:41.8
5wz2C-2px5A:66.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.